FDA Inspection 1123970 — Italfarmaco S.p.A.

Italfarmaco S.p.A. — FEI 1196

The FDA completed an inspection of Italfarmaco S.p.A. on February 1, 2019 in Milan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 1, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Milan (Italy)

Additional Details

Mutual Recognition Agreement (MRA)